Arterial occlusive disease is a condition where arteries become narrowed or blocked, reducing blood flow to the organs and limbs they supply. It affects an estimated 113.7 million people worldwide and is the underlying cause of most heart attacks, strokes, and limb amputations related to poor circulation. The narrowing almost always results from atherosclerosis, a gradual buildup of fatty deposits, calcium, and scar tissue inside artery walls.
How Arteries Become Blocked
The process starts with damage to the inner lining of an artery. High blood pressure, smoking, high cholesterol, and high blood sugar can all injure this delicate lining, making it “sticky” and permeable. Once damaged, cholesterol particles (specifically LDL, the so-called “bad” cholesterol) slip through the lining and lodge in the artery wall beneath it.
Trapped in the wall, these cholesterol particles oxidize and trigger an immune response. White blood cells rush in and try to absorb the cholesterol, swelling into what researchers call foam cells. This growing cluster of fat-laden cells forms a visible yellowish streak along the artery wall, the earliest sign of disease. Over months and years, the streak grows into a larger mass called a plaque. Smooth muscle cells migrate over the plaque and lay down a tough fibrous cap to wall it off from flowing blood. Beneath that cap sits a soft, unstable core of dead cells, cholesterol, and debris.
Areas where blood flow is turbulent, like artery branches and curves, are especially vulnerable. Turbulent flow keeps cholesterol particles in contact with the wall longer and physically disrupts the lining, making infiltration easier. This is why certain locations in the body develop blockages far more often than others.
Where It Develops
Arterial occlusive disease can strike virtually any large or medium-sized artery. The most common and clinically significant locations include:
- Leg arteries (peripheral arterial disease): The most common site outside the heart. Blockages in the arteries supplying the legs cause pain with walking and, in severe cases, tissue death.
- Heart arteries (coronary artery disease): Blockages here restrict blood flow to the heart muscle, causing chest pain and heart attacks.
- Neck arteries (carotid artery disease): Narrowing in the arteries feeding the brain raises the risk of stroke and transient ischemic attacks.
- Kidney arteries (renal artery stenosis): Reduced flow to the kidneys can cause difficult-to-control high blood pressure and kidney damage.
These locations rarely exist in isolation. Having blockages in the leg arteries, for example, significantly raises your risk of also having coronary or carotid disease, because the same systemic process is affecting arteries throughout the body.
Risk Factors
Some risk factors are within your control, and some are not. The major modifiable risks are smoking, high blood pressure, high cholesterol, diabetes, and obesity. Smoking is particularly damaging because it injures artery linings directly while also raising cholesterol and promoting blood clotting. Diabetes accelerates plaque formation through sustained high blood sugar, which damages artery walls and promotes inflammation.
Non-modifiable risks include age (especially after 65, or after 50 if other risk factors are present), a family history of arterial disease, heart disease, or stroke, and prior radiation exposure to the affected area.
How Symptoms Progress
Arterial occlusive disease in the legs follows a well-documented progression, divided into four stages. The same general pattern, from no symptoms to tissue damage, applies to other arteries as well, though the specific symptoms differ by location.
In Stage I, the artery is partially blocked but blood flow is still adequate. You have no symptoms, and the disease is only detectable through testing. Many people remain at this stage for years.
Stage II brings claudication, the hallmark symptom of peripheral arterial disease. This is a cramping, aching, or heavy feeling in the calves, thighs, or buttocks that reliably appears during walking and disappears within a few minutes of rest. The distance you can walk before pain starts indicates severity. Being able to walk more than about 200 meters (roughly two city blocks) before symptoms appear is considered mild. Less than that is moderate to severe.
Stage III means the blood supply is so compromised that pain occurs even at rest, particularly at night when you’re lying down and gravity no longer helps push blood to your feet. People at this stage often find temporary relief by dangling their legs over the side of the bed.
Stage IV is the most advanced, marked by tissue breakdown: non-healing wounds, ulcers, or gangrene. At this point, the limb is at serious risk. A large meta-analysis found that roughly one-third of patients diagnosed with critical limb-threatening ischemia face amputation within a year. Among those who do undergo amputation, another third die within the following year, highlighting how advanced arterial disease reflects dangerously compromised health overall.
How It’s Diagnosed
The simplest and most widely used screening test is the ankle-brachial index, or ABI. A clinician measures blood pressure at your ankle and your arm, then divides the ankle reading by the arm reading. A normal ratio falls between 0.9 and 1.4. A ratio below 0.9 indicates arterial narrowing and is considered diagnostic for peripheral arterial disease. A ratio below 0.5 signals critical ischemia, and below 0.3 suggests impending gangrene. Values above 1.4 point to calcified, rigid arteries (common in diabetes) and carry their own cardiovascular risks.
Most patients with claudication have an ABI between 0.5 and 0.9, though it can range as high as 1.0 or as low as 0.2 depending on the individual.
When more detail is needed about the exact location and severity of blockages, imaging comes next. Color Doppler ultrasound is typically the first imaging test because it’s noninvasive, widely available, and provides real-time information about blood flow. CT angiography and MR angiography offer more detailed maps of the arterial tree and are used for surgical planning. Traditional catheter-based angiography, where dye is injected directly into the arteries, remains the gold standard for accuracy but is more invasive, so it’s generally reserved for cases where treatment is planned during the same procedure.
Medical Treatment
For all stages of arterial occlusive disease, the foundation of treatment is controlling the underlying risk factors. This means lowering cholesterol, managing blood pressure, controlling blood sugar if you have diabetes, and above all, quitting smoking. Smoking cessation alone can slow disease progression dramatically and improve walking distance in people with claudication.
Aspirin and cholesterol-lowering medications remain the cornerstone of drug therapy. Multiple large trials have shown these reduce the risk of heart attack, stroke, and death in people with arterial disease. For patients who can’t tolerate aspirin, an alternative blood-thinning medication may be used instead. Supervised exercise programs, typically involving structured walking sessions several times a week, have been shown to significantly increase the distance people with claudication can walk before pain begins.
Procedures to Restore Blood Flow
When medications and lifestyle changes aren’t enough, particularly in advanced disease with rest pain or tissue loss, procedures to physically reopen or bypass blocked arteries become necessary. There are two main approaches.
Endovascular therapy is the less invasive option. A catheter is threaded through a small puncture in the skin to the site of the blockage, where a balloon is inflated to widen the artery. A small mesh tube (stent) is often placed to keep it open. Recovery is faster, hospital stays are shorter, and rates of bleeding, wound complications, kidney injury, and readmission are all lower compared to open surgery.
Surgical bypass is the more traditional approach. A surgeon uses either a vein from your own body or a synthetic tube to reroute blood flow around the blocked segment. A meta-analysis of over 47,000 patients found that surgery produces better long-term results for keeping the limb intact, with lower rates of major adverse limb events like worsening blockages or the need for additional procedures. However, it comes with higher rates of heart-related complications, more bleeding, and longer hospital stays.
There was no significant difference in 30-day mortality between the two approaches. The choice between them depends on the location and extent of the blockage, your overall health, and how well you can tolerate a larger operation. In many cases, a team of vascular specialists works together to determine which option gives the best balance of limb preservation and acceptable risk.
What Happens Without Treatment
Untreated arterial occlusive disease tends to worsen over time, though the pace varies. In the legs, about 10 to 15 percent of people with claudication will progress to critical limb ischemia over five years. The bigger threat is what’s happening silently elsewhere: people with peripheral arterial disease have a markedly higher risk of heart attack and stroke, because the same plaque buildup is affecting arteries throughout the body.
For those who reach the most advanced stage, where no surgical or endovascular option can restore blood flow, outcomes are sobering. In a study of these “no-option” patients, only 37 percent were alive with their limb intact at one year. Forty-five percent underwent major amputation, and a third died. Among survivors who kept their limbs, two-thirds still had non-healing wounds, and 83 percent needed help walking. These numbers underscore why early detection and aggressive risk factor management matter so much: the goal is to catch and slow the disease long before it reaches this point.